Jaguar Health has appointed biopharmaceutical industry veteran Catherine Miller Collis to the role of Senior Vice President of Growth Strategy. Miller Collis previously served as the Chief Commercial Officer at Vibrant Gastro, a company dedicated to developing and commercializing innovative therapies for gastrointestinal disorders and diseases.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JAGX:
- Jaguar Health enters in-license agreement with Venture Life Group for Gelclair
- Biotech Alert: Searches spiking for these stocks today
- Jaguar Health’s Strategic Moves to Regain Nasdaq Compliance
- Jaguar Health says topline results for trial of crofelemer are ‘forthcoming’
- Jaguar Health granted extension to regain Nasdaq compliance
